According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $73.62 M. In 2022 the company made a revenue of $82.09 M a decrease over the years 2021 revenue that were of $92.97 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $73.62 M | -10.32% |
2022 | $82.09 M | -11.7% |
2021 | $92.97 M | -8.53% |
2020 | $0.10 B | -45.9% |
2019 | $0.18 B | -21.19% |
2018 | $0.23 B | 82.68% |
2017 | $0.13 B | 159.77% |
2016 | $50.24 M | -61.89% |
2015 | $0.13 B | 6.02% |
2014 | $0.12 B | 2344.39% |
2013 | $5.08 M | -92.61% |
2012 | $68.82 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 126,250.82% | ๐บ๐ธ USA |
Novartis NVS | $51.01 B | 69,189.07% | ๐จ๐ญ Switzerland |
AbbVie ABBV | $54.31 B | 73,679.58% | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $9.86 B | 13,305.23% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 81,552.22% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.00 B | 61,031.18% | ๐บ๐ธ USA |